CD8A and neoplasm: For example, in contrast to the study published by George et al. [4], a study by Choueiri et al. [5] has reported that high CD8+ T-cell infiltration and PD-L1 positivity in tumor cells is associated with shorter survival in metastatic ccRCC treated with tyrosine kinase inhibitors.